One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Stretch Marks Treatment Market

[ 英語タイトル ] Stretch Marks Treatment Market - Growth, Trends, and Forecast (2020 - 2025)

Product Code : MDHC0089111
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 112
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Alliance Pharma PLC
- Basq Skincare
- Clarins Group
- Candela Corporation
- Dermaclara Inc.
- E.T. Browne Drug Co. Inc. (Palmers)
- Helix BioMedix Inc.
- HRA Pharma
- Laboratoires Expanscience
- Union Swiss (Pty) Ltd
- Weleda AG

[Report Description]

The stretch marks treatment market is expected to witness healthy CAGR over the forecast period. The growth of the market is majorly due to the rising burden of obesity across the world and the growing number of pregnancies because of which there is a rising concern of stretch marks in women.

As per the World Health Organization (WHO), since the year 1975, obesity has tripled worldwide. During the year 2016-2017, more than 1.9 billion adults were overweight among which over 650 million were obese. The WHO has also stated that most of the world's population lives in countries where overweight and obesity kills more people than underweight. The above statements indicate that there is a high burden of obesity in the world which is augmenting the rise in the number of people having stretch marks. This is ultimately contributing to the growth of the market studied.

Furthermore, there is a high number of pregnancies seen in the developed as well as developing countries which is also augmenting the demand for stretch mark treatment products. For instance, in the United States, there were 3,855,500 births, as per the data published by the Center for Disease Control and Prevention.

Key Market Trends

Topical Treatment Segment is Expected to Dominate the Market

The stretch mark treatment market is dominated by topical treatment. This is majorly attributed to the high cost of other treatments such as laser and Microdermabrasion. Another factor propelling the growth of this segment is the availability and ease of use of these products. Most of the females take treatment for their stretch marks at home only for which they prefer creams, lotions, or oils. Also, the price of these products is comparatively less which makes it more affordable for low to middle-income people.

In developing countries like India and South Africa, people usually go with the products that are cost-effective and easily accessible which is resulting in the high sale of topical products for stretch marks in such countries. Added to that, topical products come with fewer side effects than that of lasers which makes it more trustworthy treatment.

North America Holds the Largest Market Share

North America is expected to hold the largest share of the market studied, which is primarily due to better treatment options and the large target population in this region. The companies are also focusing more on this developed economy as there is a large demand for stretch mark treatment in the United States. As per the recent Behavioral Risk Factor Surveillance System (BRFSS) data, the adult obesity rate has exceeded 35% in most of the states from the USA. This is augmenting the demand for stretch mark treatment in these states as obesity is the prime factor for the developing stretch marks.

Competitive Landscape

The market for stretch marks treatment is moderately competitive and there are several local players that are holding the large chunk of market share. However, the market also witnesses the presence of glocal players such as Merz Pharma and Cynosure, Inc. With the rising demand for the stretch mark treatment, it is believed that more companies will be penetrating this market and hold a considerable share in the market.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Obesity Across the World
4.2.2 Increasing Number of Pregnancies and the Concern about Stretch Marks
4.3 Market Restraints
4.3.1 High Cost of Laser and Microdermabrasion Treatment
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Treatment
5.1.1 Topical Products Creams Oils and Serum Lotion
5.1.2 Laser Fractional Lasers Pulse-dye Lasers Other Lasers
5.1.3 Other Treatments
5.2 By End User
5.2.1 Hospitals and Clinics
5.2.2 Home Use
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Alliance Pharma PLC
6.1.2 Basq Skincare
6.1.3 Clarins Group
6.1.4 Candela Corporation
6.1.5 Dermaclara Inc.
6.1.6 E.T. Browne Drug Co. Inc. (Palmers)
6.1.7 Helix BioMedix Inc.
6.1.8 HRA Pharma
6.1.9 Laboratoires Expanscience
6.1.10 Union Swiss (Pty) Ltd
6.1.11 Weleda AG




Recommended reports